Skip to main content
Pacific Shuanglin Bio-pharmacy Co., LTD logo

Pacific Shuanglin Bio-pharmacy Co., LTD — Investor Relations & Filings

Ticker · 000403 ISIN · CNE000000F14 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,854 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000403

About Pacific Shuanglin Bio-pharmacy Co., LTD

https://www.slbiop.com

Pacific Shuanglin Bio-pharmacy Co., LTD specializes in the research, development, production, and distribution of plasma-derived medicinal products. The company operates a comprehensive value chain encompassing plasma collection, fractionation, and the manufacturing of critical biopharmaceuticals. Its core product portfolio includes human albumin, intravenous human immunoglobulin (IVIG), coagulation factor VIII, and various specialized immunoglobulins such as tetanus and hepatitis B human immunoglobulins. Utilizing advanced protein separation and purification technologies, the company provides essential treatments for immune deficiencies, coagulation disorders, and critical care scenarios. Pacific Shuanglin maintains a network of plasma collection centers and adheres to rigorous quality control standards to ensure the safety and efficacy of its biological products for clinical use.

Recent filings

Filing Released Lang Actions
关于回购公司股份的进展公告
Regulatory Filings
2026-06-02 Chinese
北京市嘉源律师事务所关于派斯双林生物制药股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 85% confidence The document is a formal legal opinion letter (“法律意见书”) issued by a law firm attesting to the legality of the convening, procedures, attendance and voting results of the 2025 Annual General Meeting. It is not the AGM presentation itself, nor a simple vote‐result announcement, but rather a lawyer’s certification/attestation of compliance. Under the Certification Rule, such attestations are classified as Regulatory Filings (RNS).
2026-05-22 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is an announcement of the 2025 annual general meeting (AGM) resolutions including voting results for five proposals, attendance, and legal opinions. It reports the official voting outcomes of shareholder resolutions rather than providing the full AGM materials or financial statements. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-05-22 Chinese
关于新增回购专用证券账户的公告
Transaction in Own Shares Classification · 85% confidence The document is a public announcement by a listed company regarding the opening of a new dedicated securities account for a share buyback plan. It details the repurchase scheme, loan commitment for funding the buyback, and the account information for executing the repurchase. This clearly falls under the category of a company’s own share repurchase transaction report rather than a capital raise or regulatory filing, matching the “Transaction in Own Shares” classification (POS).
2026-05-20 Chinese
关于公司股东股份质押的公告
Regulatory Filings Classification · 88% confidence The document is a shareholder equity pledge announcement (“股东股份质押的公告”), detailing the pledge of existing shares by a major shareholder. It is not the company buying back shares (POS), nor a change in shareholding thresholds (MRQ), nor an earnings or governance report. It is a regulatory disclosure of a material event that does not fit the other specific categories, so it falls under the general Regulatory Filings (RNS) category.
2026-05-20 Chinese
2026-029 关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 90% confidence The document is an official announcement by a listed company regarding its board-approved share repurchase and discloses the top ten shareholders and top ten unrestricted shareholders as required under share repurchase rules. This falls under reporting of transactions in own shares (share buybacks). It is not a capital issuance, regulatory filing, or director dealing. Therefore, the appropriate category is Transaction in Own Shares (POS).
2026-05-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.